Back to the Top
Dear All,
Considering t1/2 = 0.693 X Vdss/CL = 0.693 X MRT,
MRT should always be 1.5 times higher than t1/2. But in many PK publications, I have seen this relationship going off by a large margin. Is it just because of an inappropriate experimental design?
Thanks
Sunil
Back to the Top
Hi Sunli,
I think the equation t1/2 = 0.693 X Vdss/CL = 0.693 X MRT is only true if the drug follows one compartment model. For more complicated model, the t1/2 people report may be the terminal half life, which is different from t1/2 for a one compartment model. If they also use non-compartment analysis to deal with the data, the MRT will not be 1.5 times of t1/2.
Thanks,
Norman
--
Norman Zhou NSEC fellow, The Ohio State University College of Pharmacy
Back to the Top
The following message was posted to: PharmPK
Dear Norman
I think that you have got things a little bit complicated. The equation 0.693 x MRT can apply to drugs showing one compartment or multiple compartments and is probably the best half-life to use when assessing rise to steady-state for a multiple compartment drug. For a drug showing one compartment characteristics then 0.693 x MRT will be the terminal half-life.
The use of 0.693 x MRT is particularly useful for drugs showing diffusion rate limited kinetics where the rate constant associated with the first phase is the elimination half-life and the terminal half life reflects the transfer of drug from the peripheral compartment and is usually close in value to the micro rate constant k21. The half-life calculated from 0.693 x MRT is the effective half life - I probably shouldn't have opened that subject again!!!
regards
Brian
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "T1/2 and MRT relationship" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)